نتائج البحث - Gail Farfel
- يعرض 1 - 10 نتائج من 10
-
1
A phase I, randomized, open-label, single-dose, 3-period crossover study to evaluate the drug-drug interaction between ZX008 (fenfluramine HCl oral solution) and a regimen of stiri... حسب Ben J. Boyd, Steven M. Smith, Arnold R. Gammaitoni, Bradley S. Galer, Gail Farfel
منشور في 2018Artigo -
2
-
3
Cardiovascular safety of fenfluramine in the treatment of Dravet syndrome: Analysis of an ongoing long‐term open‐label safety extension study حسب Wyman W. Lai, Bradley S. Galer, Pierre C. Wong, Gail Farfel, Milka Pringsheim, Martin Keane, Anupam Agarwal
منشور في 2020Artigo -
4
Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adu... حسب Kim I. Bishop, Peter Κ. Isquith, Gérard A. Gioia, Arnold R. Gammaitoni, Gail Farfel, Bradley S. Galer, Rima Nabbout, Elaine Wirrell, Tilman Polster, Joseph Sullivan
منشور في 2021Artigo -
5
Fenfluramine HCl (Fintepla<sup>®</sup>) provides long‐term clinically meaningful reduction in seizure frequency: Analysis of an ongoing open‐label extension study حسب Joseph Sullivan, Ingrid E. Scheffer, Lieven Lagae, Rima Nabbout, Milka Pringsheim, Dinesh Talwar, Tilman Polster, Bradley S. Galer, Michael Lock, Anupam Agarwal, Arnold R. Gammaitoni, Glenn Morrison, Gail Farfel
منشور في 2020Artigo -
6
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens حسب Rima Nabbout, Arun Mistry, Sameer M. Zuberi, Nathalie Villeneuve, António Gil‐Nagel, Rocío Sánchez‐Carpintero, Ulrich Stephani, Linda Laux, Elaine Wirrell, Kelly G. Knupp, Catherine Chiron, Gail Farfel, Bradley S. Galer, Glenn Morrison, Michael Lock, Anupam Agarwal, Stéphane Auvin
منشور في 2019Artigo -
7
Fenfluramine in the treatment of Dravet syndrome: Results of a third randomized, placebo‐controlled clinical trial حسب Joseph Sullivan, Lieven Lagae, J. Helen Cross, Orrin Devinsky, Renzo Guerrini, Kelly G. Knupp, Linda Laux, Marina Nikanorova, Tilman Polster, Dinesh Talwar, Berten Ceulemans, Rima Nabbout, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Michael Lock, Anupam Agarwal, Ingrid E. Scheffer
منشور في 2023Artigo -
8
Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome حسب Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine Nickels, Lieven Lagae, Renzo Guerrini, Sameer M. Zuberi, Rima Nabbout, Kate Riney, Svetlana Shore, Anupam Agarwal, Michael Lock, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Ronald L. Davis, António Gil‐Nagel
منشور في 2022Artigo -
9
Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial حسب Lieven Lagae, Joseph Sullivan, Kelly G. Knupp, Linda Laux, Tilman Polster, Marina Nikanorova, Orrin Devinsky, J. Helen Cross, Renzo Guerrini, Dinesh Talwar, Ian Miller, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Arun Mistry, Glenn Morrison, Michael Lock, Anupam Agarwal, Wyman W. Lai, Berten Ceulemans
منشور في 2019Artigo -
10
Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox–Gastaut syndrome: Interim analysis of an open‐label extension study حسب Kelly G. Knupp, Ingrid E. Scheffer, Berten Ceulemans, Joseph Sullivan, Katherine Nickels, Lieven Lagae, Renzo Guerrini, Sameer M. Zuberi, Rima Nabbout, Kate Riney, Anupam Agarwal, Michael Lock, David Dai, Gail Farfel, Bradley S. Galer, Arnold R. Gammaitoni, Shikha Polega, Ronald L. Davis, António Gil‐Nagel
منشور في 2022Artigo
أدوات البحث:
موضوعات ذات صلة
Internal medicine
Medicine
Epilepsy
Fenfluramine
Psychiatry
Receptor
Serotonin
Alternative medicine
Dravet syndrome
Pathology
Pediatrics
Placebo
Anesthesia
Adverse effect
Randomized controlled trial
Lennox–Gastaut syndrome
Tolerability
Clinical endpoint
Concomitant
Confidence interval
Pharmacology
5-HT receptor
Agonist
Audiology
Bioequivalence
Chemistry
Clinical psychology
Clobazam
Cmax
Cognition